Drug Maker’s Suit Against Kentucky Regulator Over Investigation Is Speculative

Mealey's (January 11, 2023, 1:57 PM EST) -- CINCINNATI — A federal district court did not err in dismissing a biopharmaceutical company’s lawsuit against the Kentucky Public Protection Cabinet’s Department of Financial Institutions (DFI) on ripeness grounds because the DFI’s investigation into the company “is not a final administrative action,” and the company has failed to exhaust its administrative remedies under Kentucky law, a Sixth Circuit U.S. Court of Appeals panel affirmed....